Press release
Treatment-Resistant Depression (TRD) Market Expands as Rapid-Acting Therapies, Neuromodulation, and Psychedelic-Assisted Treatments Redefine Care Pathways
Treatment-Resistant Depression (TRD) Market
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72096
Keyword definition
Treatment-Resistant Depression (TRD) is generally defined as major depressive disorder that does not respond adequately to at least two antidepressants of appropriate dose and duration. Key characteristics include:
• High risk of relapse and chronicity
• Elevated suicide risk
• Severe functional impairment
• Higher hospitalization and healthcare utilization
TRD management typically includes:
• Switching antidepressant classes
• Augmentation with atypical antipsychotics, lithium, thyroid hormone
• Rapid-acting agents (esketamine, ketamine-based regimens)
• Neuromodulation (rTMS, ECT, VNS; emerging DBS)
• Assisted psychotherapy models including psychedelic-based therapies
• Measurement-based care and digital therapeutic support
Market size, CAGR and outlook
TRD represents one of the highest-value segments within the MDD market, driven by premium pricing and high unmet need.
A consensus positioning based on major market studies:
• 2024 global TRD market size: approximately USD 5.5-7.0 billion
• Forecast by 2034: USD 10.5-13.0 billion
• Expected CAGR: ~7-9% over the forecast period
Growth is accelerated by:
• Strong uptake of esketamine nasal spray in the US and parts of Europe
• Expanding ketamine infusion clinics
• Wider reimbursement of rTMS
• Late-stage development of psychedelic-assisted therapies (psilocybin, MDMA-adjacent compounds)
• Significant disease burden and increasing diagnosis rates
Key players
The TRD competitive landscape includes large psychiatric drug manufacturers, neuromodulation companies, and emerging psychedelic-therapy developers.
Pharmaceutical & Biotech Companies
• Johnson & Johnson (Janssen) - Spravato (esketamine), the leading branded TRD therapy
• Allergan / AbbVie - atypical antipsychotics and augmentation strategies
• Otsuka / Lundbeck - Rexulti (brexpiprazole) augmentation; CNS portfolio
• Intra-Cellular Therapies - lumateperone as adjunctive potential
• Sage Therapeutics / Biogen (Supernus now acquiring assets) - neurosteroids (zuranolone) for depressive episodes
• Relmada Therapeutics - REL-1017 (NMDA modulator) in development
• COMPASS Pathways - COMP360 psilocybin-assisted therapy in Phase 3
• MAPS PBC - MDMA-assisted therapies (TRD-adjacent applications)
Device & Neuromodulation Companies
• Neuronetics - rTMS systems
• BrainsWay - Deep TMS
• MagVenture, Magstim - TMS device manufacturers
• LivaNova - VNS systems
• Research-stage DBS innovators in treatment-resistant cases
Behavioral Health & Digital Therapeutics
• Digital therapy companies offering CBT apps, telepsychiatry, and measurement-based care platforms
• Ketamine-assisted therapy centers and integrated mental-health clinics
Market segmentation and growth insights
By treatment modality
Pharmacological treatments (largest revenue segment)
• SSRIs/SNRIs are ineffective in TRD but still precede escalation.
• Esketamine and atypical antipsychotic augmentation drive value in reimbursed markets.
• Ketamine infusions expanding through private/clinic networks.
Neuromodulation (fastest-growing high-value segment)
• rTMS widely adopted with growing insurance coverage.
• ECT remains gold standard for severe suicidality.
• Deep TMS and VNS expanding into niche refractory populations.
Psychedelic-assisted therapies (emerging premium segment)
• Late-stage trials show durable responses following structured sessions.
• Expected commercialization around 2025-2027 in first markets.
Digital therapeutics & measurement-based care
• Used as adjuncts to track symptoms and improve outcomes; enhances real-world effectiveness of TRD treatments.
By disease management pathway
• Second-line TRD (after two antidepressants) - rapid expansion due to esketamine approvals
• Multi-therapy-resistant TRD - highest spending per patient (ECT, ketamine, rTMS, multi-drug regimens)
• Chronic, recurrent TRD - long-term maintenance costs; strong opportunity for digital and integrated care models
By end user
• Hospitals & psychiatric centers
• Specialty mood-disorder clinics
• Neuromodulation centers (rTMS, ECT)
• Ketamine infusion centers
• Behavioral health networks & telepsychiatry platforms
Explore Full Report here: https://exactitudeconsultancy.com/reports/72096/treatment-resistant-depression-trd-market
Regional insights
North America
• Largest TRD market globally; high esketamine use, broad TMS reimbursement, rapidly expanding ketamine clinics
• Strong investment in psychedelic-therapy research
Europe
• Significant adoption of esketamine, though shaped by HTA reviews and cost constraints
• rTMS availability growing steadily
• Structured mental-health frameworks support TRD diagnosis and management
Asia-Pacific
• Fastest growth due to rising depression prevalence, expanding psychiatric infrastructure, and early adoption of neuromodulation in Japan, South Korea, Australia
• Private clinic expansion supports ketamine-based treatments
Latin America & Middle East/Africa
• Emerging markets with growing demand for non-opioid, non-benzodiazepine mental health therapies
• Limited access to high-cost esketamine or TMS devices but improving urban availability
Key market drivers
• High unmet need: 30-40% of patients do not achieve remission with standard antidepressants
• Demand for rapid-acting therapies: esketamine and ketamine clinics meet urgent clinical needs
• Non-monoaminergic innovation: psychedelics, neurosteroids, NMDA modulators, novel glutamatergic agents
• Expansion of neuromodulation: rTMS, Deep TMS, VNS, and emerging DBS applications
• Increased mental-health funding: post-pandemic mental health focus from governments and employers
• Growing awareness and diagnosis of TRD as a distinct clinical segment
Challenges include high cost of novel agents, reimbursement variability, limited long-term data for psychedelics, and workforce shortages in psychiatry.
Conclusion
The Treatment-Resistant Depression (TRD) market is emerging as one of the most dynamic segments in mental health, characterized by:
• A growing patient pool with unmet needs
• A shift from generic antidepressants to rapid-acting and neuromodulation-based therapies
• A strong innovation wave in psychedelics and novel mechanisms
With:
• 2024 market size: USD 5.5-7.0 billion,
• 2034 forecast: USD 10.5-13.0 billion,
• CAGR: ~7-9%,
TRD represents a major growth driver within the broader depression market.
Companies that invest in:
• Mechanistically differentiated drugs
• Multimodal care combining pharmacotherapy, neuromodulation, and psychotherapy
• Digital tools supporting adherence and real-world outcomes
will be best positioned to lead in the next decade of TRD care.
This report is also available in the following languages : Japanese (治療抵抗性うつ病(TRD)市場), Korean (치료 저항성 우울증(TRD) 시장), Chinese (难治性抑郁症(TRD)市场), French (Marché de la dépression résistante au traitement (DRT)), German (Markt für behandlungsresistente Depression (TRD)), and Italian (Mercato della depressione resistente al trattamento (TRD)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72096
Our More Reports:
Arsenic Removal Market
https://exactitudeconsultancy.com/reports/75958/arsenic-removal-market
Ozone Generators Market
https://exactitudeconsultancy.com/reports/76046/ozone-generators-market
Alzheimer's Disease Treatment Market
https://exactitudeconsultancy.com/reports/76109/alzheimer-s-disease-treatment-market
Post-harvest Treatment Market
https://exactitudeconsultancy.com/reports/76145/post-harvest-treatment-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Treatment-Resistant Depression (TRD) Market Expands as Rapid-Acting Therapies, Neuromodulation, and Psychedelic-Assisted Treatments Redefine Care Pathways here
News-ID: 4302850 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for TRD
Treatment-Resistant Depression (TRD) Market Expands as Novel Mechanisms, Rapid-A …
The Treatment-Resistant Depression (TRD) Market is entering one of the most dynamic phases in the history of psychiatry. Traditional monoaminergic antidepressants leave a large share of patients with partial or no response. This unmet need is fueling demand for rapid-acting drugs, NMDA-targeting agents, neuromodulation devices, digital therapeutics, and more personalized treatment pathways. Over the next decade, TRD will be a core focus area for pharma, med-tech, and digital health companies…
United States Treatment-Resistant Depression (TRD) Market Boom | Top Companies, …
DataM Intelligence has released an in-depth research report on "Treatment-Resistant Depression Market Size 2025". This report delivers power-packed insights into key growth drivers, market segmentation, regional trends, CAGR forecasts, revenue performance of top players, and emerging opportunities. Gain a 360° market perspective with detailed analysis on value, volume, and future development trends your ultimate guide to spotting high-impact opportunities and staying ahead in this dynamic market.
Mergers & Acquisitions
The TRD market…
Treatment-Resistant Depression (TRD) Market Growth, Trends, Consumer Demand and …
Introduction
Depression is one of the most common mental health disorders worldwide. While many patients respond positively to first-line antidepressant therapies, a significant proportion fail to achieve remission even after multiple treatment attempts. This subgroup is diagnosed with treatment-resistant depression (TRD), a severe and disabling condition that increases the risk of hospitalization, suicide, and chronic functional impairment.
With growing global recognition of mental health as a public health priority, there is an…
Autosculpt Market Next Big Move | Major Giants ABT, Shelby, TRD, BMW, Benz
The latest report released on Autosculpt Market - Global Outlook and Forecast Market analyses areas where there is still room for improvement. Irrespective of industry, organization size, or geographic location, the Autosculpt Market - Outlook and Forecast Market study suggests that advanced technologies are playing a bigger role than ever before. The market Study is segmented by key a region that is accelerating the marketization. The assessment provides trends, growth…
Treatment-resistant Depression (TRD) Market Global Research and Clinical Survey …
“The Treatment-resistant Depression (TRD) Market Research Report” examines the existing as well as sequential performance of the worldwide market. The report also calculates the forthcoming status of Treatment-resistant Depression (TRD) market based on thorough analysis. By providing exploratory techniques such as, qualitative and quantitative analysis the report presents a comprehensive analysis of market progression. The report provides Graphical presentation of information through charts, (graphs, diagrams as well as pictures) and…
Global Handheld Gimbal Market : Feiyu, Freefly, DJI Tech, Wondlan, Rollei, TRD F …
Handheld Gimbal is a pivoted support that cooperates with the light photographic equipment, such as mainstream sports cameras, mobile phones, micro single which lets the consumer get more stable video material in the movement, and handheld gimbal itself is small, portable, easy operation, etc..
Get a Sample of Handheld Gimbal Market research report from @ http://www.globalinforeports.com/request-sample/247721
Scope of the Report:
This report focuses on the Handheld Gimbal…
